0001209191-16-133851.txt : 20160725 0001209191-16-133851.hdr.sgml : 20160725 20160725170844 ACCESSION NUMBER: 0001209191-16-133851 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160725 FILED AS OF DATE: 20160725 DATE AS OF CHANGE: 20160725 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures IV, LLC CENTRAL INDEX KEY: 0001456589 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37833 FILM NUMBER: 161782622 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-2211 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-25 1 0001628738 Audentes Therapeutics, Inc. BOLD 0001456589 Versant Ventures IV, LLC ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 Common Stock 2016-07-25 4 C 0 1081477 A 1081477 I By Versant Venture Capital IV, L.P. Common Stock 2016-07-25 4 C 0 480856 A 1562333 I By Versant Venture Capital IV, L.P. Common Stock 2016-07-25 4 C 0 198410 A 1760743 I By Versant Venture Capital IV, L.P. Common Stock 2016-07-25 4 C 0 6811 A 6811 I By Versant Side Fund IV, L.P. Common Stock 2016-07-25 4 C 0 3029 A 9840 I By Versant Side Fund IV, L.P. Common Stock 2016-07-25 4 C 0 1249 A 11089 I By Versant Side Fund IV, L.P. Common Stock 2016-07-25 4 P 0 34781 15.00 A 1795524 I By Versant Venture Capital IV, L.P. Common Stock 2016-07-25 4 P 0 219 15.00 A 11308 I By Versant Side Fund IV, L.P. Series A Preferred Stock 2016-07-25 4 C 0 1081477 D Common Stock 1081477 0 I By Versant Venture Capital IV, L.P. Series B Preferred Stock 2016-07-25 4 C 0 480856 D Common Stock 480856 0 I By Versant Venture Capital IV, L.P. Series C Preferred Stock 2016-07-25 4 C 0 198410 D Common Stock 198410 0 I By Versant Venture Capital IV, L.P. Series A Preferred Stock 2016-07-25 4 C 0 6811 D Common Stock 6811 0 I By Versant Side Fund IV, L.P. Series B Preferred Stock 2016-07-25 4 C 0 3029 D Common Stock 3029 0 I By Versant Side Fund IV, L.P. Series C Preferred Stock 2016-07-25 4 C 0 1249 D Common Stock 1249 0 I By Versant Side Fund IV, L.P. Each share of the issuer's Series A Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-208842) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date. Versant Ventures IV, LLC ("VV IV") is the general partner of Versant Venture Capital IV, L.P. ("VVC IV"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Each of Thomas Woiwode, a member of the issuer's board of directors, Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden is a managing member of VV IV and may be deemed to share voting and dispositive power over the securities held by VVC IV. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Each share of the issuer's Series B Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date. Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date. VV IV is the general partner of Versant Side Fund IV, L.P. ("VSF IV"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Each of Thomas Woiwode, a member of the issuer's board of directors, Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden is a managing member of VV IV and may be deemed to share voting and dispositive power over the securities held by VSF IV. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. /s/ Robin L. Praeger, Managing Director of Versant Ventures IV, LLC, which is the general partner of each of Versant Venture Capital IV, L.P. and Versant Side Fund IV, L.P. 2016-07-25